Eden vs Henry Meds: Medication Formats and Pricing Compared

The Eden vs Henry Meds question is really a question about medication format and how each brand prices it. This PlexusDx Education Hub review compares what each dispenses, how the money is structured, and the metabolic layer neither one measures. See all Peptides & GLP-1 education.

Full head-to-head: PlexusDx vs Henry Meds →

Full head-to-head: PlexusDx vs Eden →

Independent editorial review: PlexusDx has no commercial relationship with Henry Meds, Eden, or their parent companies. No affiliate links or compensation are involved.

As of July 2026, Eden and Henry Meds are two of dozens of telehealth GLP-1 programs. This comparison focuses on the two named here and where they genuinely diverge.

Two telehealth programs, two dispensing styles

Both Eden and Henry Meds run on telehealth plus compounded pharmacy: a virtual evaluation, a provider-issued prescription, and fulfillment through licensed pathways. Where they part ways is format. Eden dispenses injectable compounded semaglutide and tirzepatide only. Henry Meds offers injectable semaglutide but provides its tirzepatide in oral form only. Current details sit on Henry Meds's website and Eden's website.

How Eden prices its GLP-1 track

Eden advertises $99/month for compounded semaglutide and $199/month for tirzepatide, medication only. A required Eden Membership ($99/month, disclosed in Eden's own footnote) lifts the true all-in cost to $198/month for semaglutide and $298/month for tirzepatide. Eden bills monthly only, dispenses injections only, charges nothing until a provider approves, and offers a money-back warranty: lose 10% of body weight in six months or get your money back.

How Henry Meds prices its GLP-1 track

Henry Meds lists injectable semaglutide at $297/month month-to-month; its advertised $197/month rate requires a 12-month prepaid commitment. Its tirzepatide comes in oral form only, at $1,047 per three-month supply or $891 paid in full. Henry Meds charges no consultation fees, and its refund policy is not stated. Eden and Henry Meds figures verified July 2026. Confirm current pricing on each brand's own site.

Where PlexusDx protocols land

For comparison, PlexusDx runs month-to-month at $189 for Semaglutide Injection and $289 for Tirzepatide Injection, with Semaglutide Oral at $289/month and Tirzepatide Oral at $349/month. Between these three programs, the format you want, injectable or oral, often decides the shortlist as much as the monthly figure does.

The evidence tracks the compound

Format aside, the pharmacology belongs to the molecule. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide were studied in STEP (semaglutide, NEJM 2021), SURMOUNT (tirzepatide, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Effect sizes vary by compound, dose, and population, whether the drug is delivered by injection or orally.

The genetic variable neither program measures

Neither Eden nor Henry Meds reads the inherited terrain a GLP-1 compound acts on. FTO, the fat-mass and obesity-associated gene, and GLP1R, the receptor these compounds bind, describe that biology; they are context, not response predictions. The PlexusDx Precision Peptide Genetic Test maps 14 pathways, 49 peptides, 150+ genetic insights, sitting alongside the Weight Management Protocols so the profile and the format decision are considered together.

Not affiliated: PlexusDx is independent of both Henry Meds and Eden and has no commercial relationship with the companies reviewed above.

Related reading on PlexusDx: What Is GLP 1, GLP 1 What Is, GLP 1 Receptor Agonist, GLP 1 Drugs.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds or Eden and offers semaglutide and tirzepatide through its own Weight Management Protocols. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related pathways and does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols for semaglutide and tirzepatide, or begin upstream with the Precision Peptide Genetic Test to map your GLP-1 pathway before you commit.

Frequently Asked Questions

Do Eden and Henry Meds offer the same medication formats?

No. Eden dispenses injectable compounded semaglutide and tirzepatide only. Henry Meds offers injectable semaglutide but delivers its tirzepatide in oral form only. If format is a priority for you, this is one of the clearest differences between the two programs, so confirm current options on each site.

How do the two programs compare on price?

Eden's all-in cost is $198/month for semaglutide and $298/month for tirzepatide. Henry Meds lists injectable semaglutide at $297/month month-to-month (or $197/month on a 12-month prepaid plan) and oral tirzepatide at $1,047 per three-month supply. Figures verified July 2026; confirm current terms directly.

Does either charge consultation or membership fees?

They differ. Eden requires a $99/month membership on top of its medication price and does not charge until a provider approves. Henry Meds charges no consultation fees, though its refund policy is not stated. Read each brand's terms before enrolling.

Can the Precision Peptide Genetic Test tell me which format will work better?

No. It does not predict response to injectable or oral therapy, or to any specific program. It reads pathway-level variants such as FTO that describe your baseline GLP-1 biology, the upstream context that applies regardless of format or platform.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education